Bactroban® (mupirocin) is licensed for the treatment of various bacterial infections, such as impetigo (a skin condition primarily affecting children) and methicillin-resistant Staphylococcus aureus (MRSA). In fact, this drug is one of the primary methods used to manage a MRSA outbreak, and is often given to healthcare workers and adults in institutionalized settings during such times.
There are three different forms of Bactroban: nasal ointment, skin ointment, and skin cream. The nasal ointment is the form used during a MRSA outbreak. The nasal passages are often where the bacteria are located in people who are "carriers." By ridding the nasal passages of this bacteria, the spread of infection can sometimes be reduced.
When using the nasal form of Bactroban, the medication is applied in each nostril twice a day for five days. Then, the nostrils should be repeatedly pinched together and released for one minute. This helps ensure that the ointment is distributed evenly throughout the nasal passages.
(Click Bactroban to learn about the other forms of Bactroban, how this medication works, possible side effects, and what you should tell your healthcare provider before beginning treatment.)